Vol.34,Issue 2,March 2013

Bevacizumab for the treatment of recurrent ovarian cancer: a retrospective cohort study

UGT1A1 genotype-specific phase I and pharmacokinetic study for combination chemotherapy with irinotecan and cisplatin: a Saitama tumor board study

Analysis of the risk factors for the recurrence of cervical cancer following ovarian transposition

The correlation between expression of synuclein-γ, glucose transporter-1, and survival outcomes in endometrioid endometrial carcinoma

Differential gene expression profile in cervical cancer and parenchyma infected with human papillomavirus 16 screened by cDNA microarray

Nodal involvement evaluation in advanced cervical cancer: a single institutional experienc

Mifepristone sensitizing cisplatin for cervical adenocarcinoma HeLa cell sensitivity to chemotherapy and its mechanism

Diagnostic value of CA125 as a predictor of recurrence in advanced ovarian cancer

Livin and caspase-3 expression are negatively correlated in cervical squamous cell cancer

Laparoscopically-assisted radical vaginal hysterectomy with five years follow-up: a case control study

Analysis of one year follow-up of women with cervical cytology report of atypical squamous cells and the diagnostic role of high-risk HPV infection

The value of mesothelin in the diagnosis and follow-up of surgically treated ovarian cancer

How to prevent the iatrogenic diffusion of gynecological malignant tumors?

The regulation network and network motif analysis in ovarian cancer

An analysis of Turkey’s scientific contribution in ovarian cancer research

Sustainable complete remission in recurrence yolk sac tumor patient treated with tandem high-dose chemotherapy and autologous stem cell

Endometrial adenocarcinoma in a young woman